CIK 0001585608
- Non-accelerated filer
- Smaller reporting company
Jaguar Health, Inc.
Sign in to watch- Ticker
- JAGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 415-371-8300
- Business address
- 200 PINE STREET SUITE 400, SAN FRANCISCO, CA, 94104
- Former names
- Jaguar Animal Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-06 | Jayasuriya Anula Director | Grant or award · Restricted stock units | −1,718 | 1,718 | ||
| 2023-04-05 | Chaturvedi Pravin R Chief Scientific Officer | Option exercise | +133 | 266 | ||
| 2023-04-05 | Chaturvedi Pravin R Chief Scientific Officer | Grant or award · Restricted stock units | +133 | 134 | ||
| 2023-04-05 | Chaturvedi Pravin R Chief Scientific Officer | Option exercise | +44 | 88 | ||
| 2023-04-05 | Chaturvedi Pravin R Chief Scientific Officer | Grant or award · Restricted stock units | +44 | 44 | ||
| 2023-04-05 | Lizak Carol R. Chief Financial Officer | Option exercise | +60 | 226 | ||
| 2023-04-05 | Lizak Carol R. Chief Financial Officer | Grant or award · Restricted stock units | +60 | 60 | ||
| 2023-04-05 | Wolin Jonathan S. Chief of Staff, CCO & GC | Option exercise | +88 | 181 | ||
| 2023-04-05 | Wolin Jonathan S. Chief of Staff, CCO & GC | Grant or award · Restricted stock units | +88 | 88 | ||
| 2023-04-05 | King Steven R. Chief of Sustainable Supply | Option exercise | +177 | 354 | ||
| 2023-04-05 | King Steven R. Chief of Sustainable Supply | Grant or award · Restricted stock units | +177 | 177 | ||
| 2023-04-05 | CONTE LISA A CEO and President | Option exercise | +600 | 1,306 | ||
| 2023-04-05 | CONTE LISA A CEO and President | Grant or award · Restricted stock units | +600 | 600 | ||
| 2022-12-31 | Wolin Jonathan S. Chief of Staff, CCO & GC | Purchase | +317 | $0.03 | $10 | 6,983 |
| 2022-12-27 | Chaturvedi Pravin R Chief Scientific Officer | Returned to the company · Employee Stock Option (right to buy) | −31,667 | 0 | ||
| 2022-12-27 | Wolin Jonathan S. Chief of Staff, CCO & GC | Returned to the company · Employee Stock Option (right to buy) | −21,112 | 0 | ||
| 2022-12-27 | Lizak Carol R. Chief Financial Officer | Returned to the company · Employee Stock Option (right to buy) | −14,294 | 0 | ||
| 2022-12-27 | King Steven R. Chief of Sustainable Supply | Returned to the company · Employee Stock Option (right to buy) | −42,223 | 0 | ||
| 2022-12-27 | CONTE LISA A CEO and President | Returned to the company · Employee Stock Option (right to buy) | −142,500 | 0 | ||
| 2022-05-18 | Divis Gregory J Director | Option exercise | +12,133 | 12,133 |
Page 7 of 10 · 185 trades